» Articles » PMID: 3973901

Synthesis and Antiarrhythmic and Parasympatholytic Properties of Substituted Phenols. 3. Modifications to the Linkage Region (region 3)

Overview
Journal J Med Chem
Date 1985 Mar 1
PMID 3973901
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

As part of a continuing program of systematically modifying the structure of the class I antiarrhythmic drug changrolin, we synthesized 15 analogues in which the linkage between the two aromatic regions was altered. High antiarrhythmic activity and low parasympatholytic activity was found when the linkage region, designated region 3, contained a carbonyl moiety, including ketones, amides, and ureas. Secondary amides were superior to tertiary amides, while amide reversal resulted in no change in activities. One compound in this series, 7, 2,6-bis(1-pyrrolidinyl-methyl)-4-benzamidophenol (ACC-9358), is undergoing preclinical evaluations.

Citing Articles

Microwave-assisted chemoselective synthesis and photophysical properties of 2-arylazo-biphenyl-4-carboxamides from hydrazonals.

Alazemi A, Dawood K, Al-Matar H, Tohamy W RSC Adv. 2023; 13(36):25054-25068.

PMID: 37614785 PMC: 10442861. DOI: 10.1039/d3ra04558g.


Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).

Bavo F, Pallavicini M, Pucci S, Appiani R, Giraudo A, Oh H J Med Chem. 2022; 66(1):306-332.

PMID: 36526469 PMC: 9841521. DOI: 10.1021/acs.jmedchem.2c01256.


Design, synthesis and biological evaluation of a new thieno[2,3-]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines.

Sharaky M, Kamel M, Aziz M, Omran M, Rageh M, Abouzid K J Enzyme Inhib Med Chem. 2020; 35(1):1641-1656.

PMID: 32781854 PMC: 7470147. DOI: 10.1080/14756366.2020.1804383.


Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition.

Elmeligie S, Aboul-Magd A, Lasheen D, Ibrahim T, Abdelghany T, Khojah S J Enzyme Inhib Med Chem. 2019; 34(1):1347-1367.

PMID: 31322015 PMC: 6691788. DOI: 10.1080/14756366.2019.1642883.


Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.

Aziz M, Serya R, Lasheen D, Abdel-Aziz A, Esmat A, Mansour A Sci Rep. 2016; 6:24460.

PMID: 27080011 PMC: 4832243. DOI: 10.1038/srep24460.